HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer gene therapy represents a cutting-edge approach in the field of oncology that focuses on manipulating the genetic material within cancer cells to either inhibit their growth or induce cell death. The underlying principle involves introducing therapeutic genes into the patient's cells to modify their behavior and enhance the body's natural ability to fight cancer. Gene therapy holds the potential to address the fundamental genetic abnormalities driving cancer development, offering a targeted and personalized treatment strategy. Various techniques, including viral vectors or direct introduction of therapeutic genes, are employed to deliver the genetic material into cancer cells, aiming to correct or disrupt the faulty cellular processes that contribute to tumor growth.
There are several types of cancer gene therapies designed to target different aspects of cancer biology. Suicide gene therapy involves introducing genes that, when activated, induce the death of cancer cells. Oncolytic virotherapy utilizes modified viruses to selectively infect and destroy cancer cells while sparing normal tissues. Additionally, immunogene therapy aims to enhance the body's immune response against cancer by introducing genes that stimulate the immune system. These innovative approaches are part of a rapidly evolving field that holds great promise for revolutionizing cancer treatment, providing more precise and effective therapeutic options for patients. While ongoing research continues to refine the safety and efficacy of cancer gene therapy, it represents a beacon of hope for advancing the forefront of cancer care.
